Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (3 quarters reported)
$33.9M in Q1 2023 → $1.72M now. Hover for any quarter.
As reported for the quarter ended September 30, 2023. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Inogen Inc | 100.0% | Unchanged | 330,000 | $1.72M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 2 quarters.
quarter ended September 30, 2023 · filed November 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Eqrx Inc | Exited | −13,935,623 | −$25.9M | — |
quarter ended June 30, 2023 · filed July 21, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| PT Pear Therapeutics Inc | Exited | −10,859,050 | −$2.77M | — |
Loading...
